Sign up to save your podcasts
Or
Share Optimizing the Identification of HER2-Low Breast Cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Optimizing the Identification of HER2-Low Breast Cancer
Dr Kimberly H Allison from the Stanford Cancer Institute in Stanford, California discusses the optimal identification, pathologic reporting and treatment of HER2-low breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
View all episodes
By Research To Practice
5
66 ratings
Dr Kimberly H Allison from the Stanford Cancer Institute in Stanford, California discusses the optimal identification, pathologic reporting and treatment of HER2-low breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
More shows like Oncology Today with Dr Neil Love
View all
Breast Cancer Update
66 Listeners
Lung Cancer Update
30 Listeners
Hematologic Oncology Update
74 Listeners
Prostate Cancer Update
13 Listeners
Gastrointestinal Cancer Update
17 Listeners
Gastrointestinal Cancer Update
4 Listeners
Oncology Today with Dr Neil Love
2 Listeners
Gynecologic Oncology Update
12 Listeners
Dermatologic Oncology Update
0 Listeners
Research To Practice | Oncology Videos
122 Listeners